Why Gasporox stock moves
Gasporox rose against the market.
Written after the close on ·
Why today
16,415 news analyzed todayGasporox rose against the market.
The market fell clearly that day, while Gasporox rose clearly on heavy trading.
No company news from that session explains the move.
Over the last five trading days, Gasporox was roughly unchanged, in line with a flat market.
The stock sits well below its high of early May and above its late-October low.
Today's move of +2.98% was 1.7 times a normal day's 1.7%. OMX Stockholm 30 moved −1.01% on the same day.
Gasporox +2.98%OMX Stockholm 30 −1.01%Against the market
Has the share price followed the business?
Price and earnings moved in the same direction: 3 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed −14% and earnings per share went from -0.30 SEK to -0.82 SEK.
Revenue, profit and market cap
RevenueProfitMarket capm SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capm SEK
Price and earnings moved in the same direction: 3 out of 3 years.Market cap (Now): 45.3 m SEKRevenue 2025: 31.6 m SEK
What the key figures say about Gasporox
The figures connect what Gasporox earns with what investors pay.
The line shows the share price in the same year, on its own scale.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -0.82 SEK–-0.14 SEK. Peers: Wirtek -0.31 DKK, Zaplox -0.02 SEK, Image Systems -0.39 SEK.
What the company sold during the year.
2022–2025: 21.4 m SEK–34.1 m SEK. Peers: Wirtek 64.0 m DKK, Zaplox 18.1 m SEK, Image Systems 112 m SEK.
The percentage of revenue left after the costs of running the business.
2022–2025: −23.2%–−4.2%. Peers: Wirtek 2.9%, Zaplox 12.5%, Image Systems −34.7%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −38.8%–−5.4%. Peers: Wirtek 3.9%, Zaplox −69.5%, Image Systems −36.3%.
What investors pay for each unit the company sells.
2022–2025: 2.22–4.07. Peers: Wirtek 0.44, Zaplox 1.78, Image Systems 0.70.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: -1.31–19.80. Peers: Wirtek 3.16.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 3.03–4.99. Peers: Wirtek 1.93, Image Systems 0.78.
Cash left after investments, divided by the number of shares.
2022–2025: -1.34 SEK–-0.38 SEK. Peers: Wirtek -0.70 DKK, Zaplox -0.02 SEK, Image Systems -0.28 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 39.2%–66.8%.
Earnings report
On its last 16 report days Gasporox usually moved about 6.4%. On a normal day it moves 1.7%.
−20.86% Why? −0.74% +3.87% +7.35%
10,000 SEK in Gasporox bought on November 7, 2016 is worth 3,030 SEK today, with dividends reinvested.
What would 10,000 SEK in Gasporox be worth today? →
What would 10,000 SEK in Gasporox be worth today?
3,030 SEK
with dividends reinvested, bought on November 7, 2016.
At worst it was worth 2,790 SEK (October 28, 2026).
The five biggest days of the journey
· +32.0% · the whole market rose 0.7% the same day
· +26.9% · the whole market rose 1.1% the same day
· +25.7% · the whole market rose 2.6% the same day
· −25.2% · the whole market fell 0.1% the same day · report day
· +22.6% · the whole market rose 1.0% the same day
Earlier days
−0.82% market −0.11% Gasporox was roughly unchanged over the week, while the broader OMX Stockholm 30 market was also flat. Read →
Gasporox was roughly unchanged over the week, while the broader OMX Stockholm 30 market was also flat.
The stock rose clearly in the last session as the market fell, and it traded heavily, about three times a normal day's volume.
Its weak earlier quarter, with lower sales and an operating loss, is background.
Technology stocks on Nasdaq First North Sweden fell slightly over the same days, which suggests the sector was not the driver.
−2.49% market −0.32% Gasporox fell clearly, without company news. Read →
Gasporox fell clearly, without company news.
No company news from the last session explains the drop.
Over the last five trading days the shares were roughly unchanged, while OMX Stockholm 30 rose slightly.
Trading was about three times a normal day, so the fall drew heavy volume.
The likely background is earlier news: the company reported weaker third-quarter sales, with sales down to 3.9 MSEK and an operating loss of 4.1 MSEK, and its CEO called the situation tough.
−0.41% market +0.83% Gasporox held steady as the market rose. Read →
Gasporox held steady as the market rose.
Over the last five trading days, Gasporox rose clearly, more than the broader Stockholm market.
Its share price is far below its high from early May and above its low from late October.
No company news explains the flat session; trading volume was roughly double its normal level.
The next earnings report is due Thursday 18 February 2027.
−0.41% market −0.08% Gasporox held roughly steady, with the market flat. Read →
Gasporox held roughly steady, with the market flat.
Over the last five trading days Gasporox fell clearly while OMX Stockholm 30 rose slightly, so it lagged the market.
Its recent weakness likely reflects a weak third quarter, with sales down and an operating loss, plus pressure in China.
The company's own message said the year's first nine months still showed higher sales than last year.
No company news explains the flat move in the last session, and trading volume was well below its usual level.
−0.41% market +0.48% Gasporox was roughly unchanged without a company-news explanation. Read →
Gasporox was roughly unchanged without a company-news explanation.
Over the last five trading days it fell slightly, while OMX Stockholm 30 rose clearly, so it lagged the market.
The move was an ordinary size for Gasporox.
Its quarterly sales fell after a run of strong quarters, and the company pointed to weaker demand in China.
−12.07% market +3.01% Gasporox fell sharply over the week, a big move for the stock, while the OMX Stockholm 30 rose clearly, so it moved against the market. Read →
Gasporox fell sharply over the week, a big move for the stock, while the OMX Stockholm 30 rose clearly, so it moved against the market.
The likely driver is its weak third-quarter report, published 22 October, which showed sales falling sharply and an operating loss, with lower sales in China cited as a cause.
Trading was heavy, about three times normal, which suggests many investors reacted to that news.
The company's next earnings report is due on Thursday 18 February 2027.
+6.73% market +0.41% Gasporox rose sharply, moving ahead of the market. Read →
Gasporox rose sharply, moving ahead of the market.
No company news from that session explains the move.
Over the last five trading days, the stock fell sharply, against a sharp rise in OMX Stockholm 30.
The latest report, Q3 2026, showed weaker sales in the quarter, with net sales down to 3.9 MSEK, and an operating loss, as Chinese demand fell.
That report came out before the last session, so it is background.
−13.40% market +0.33% Gasporox fell very sharply without a company-news explanation. Read →
Gasporox fell very sharply without a company-news explanation.
Gasporox fell very sharply over the last five trading days, while OMX Stockholm 30 rose slightly.
The drop is very large by Gasporox's usual standards and was among its biggest of the past year.
The most recent company news was a weak third-quarter report, published before the last session, showing sales of 3.9 MSEK.
The CEO also called the situation 'tough' the day before the session.
+3.00% market +0.96% Gasporox rose clearly, more than OMX Stockholm 30. Read →
Gasporox rose clearly, more than OMX Stockholm 30.
The CEO's comment on the tough situation came out that day, but it is not clearly the reason for the rise.
Over the last five trading days Gasporox fell very sharply while the market stayed roughly flat.
Trading volume was far above normal for Gasporox in the last session.
The next earnings report is due on 18 February 2027.
−9.91% market +1.57% Gasporox fell, moving against a market that rose clearly. Read →
Gasporox fell, moving against a market that rose clearly.
No company news from that session explains the move.
Over the last five trading days the stock fell very sharply, far more than the market's slight decline.
Its most likely background is the weak third-quarter report published last week, which showed net sales falling and a larger operating loss, partly from weaker sales in China.
The next earnings report is on Thursday 18 February 2027.
+0.91% market +0.41% Gasporox rose slightly, with no company news from that day explaining it. Read →
Gasporox rose slightly, with no company news from that day explaining it.
Over the same day OMX Stockholm 30 also rose slightly, so the move was in line with the market.
Over the last five trading days Gasporox fell sharply, far more than the market.
The latest company report, Q3 2026, came out the day before the last session and showed weaker sales and a larger operating loss.
Next, watch the next earnings report on Thursday 18 February 2027.
−13.95% market −3.67% Gasporox fell sharply over the last five trading days, more than the OMX Stockholm 30 index, which also fell. Read →
Gasporox fell sharply over the last five trading days, more than the OMX Stockholm 30 index, which also fell.
The move was very big for this stock, rare in the past year.
The main cause was its third-quarter report, published yesterday: net sales fell sharply and the company posted an operating loss, partly because sales in China dropped.
Management said the weaker quarter reflected lumpy deliveries and a new competitive situation in China.
−20.86% market −2.51% Gasporox falls sharply after weak third-quarter report. Read →
Gasporox falls sharply after weak third-quarter report.
Gasporox fell very sharply in the last session, on the day it published its third-quarter report.
The market fell sharply too, so Gasporox moved far more than the index.
Management blamed weaker sales in China and a new competitive situation.
Learn more · Why do stocks go up and down?